Equities
  • Price (CHF)4,225.00
  • Today's Change-14.00 / -0.33%
  • Shares traded13.15k
  • 1 Year change+40.09%
  • Beta0.9702
Data delayed at least 15 minutes, as of May 24 2024 16:32 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Givaudan SA is a Switzerland-based company engaged in the fragrance and flavor industry. The Company has two business divisions: Fragrances and Flavors. The Fragrances segment comprises the manufacture and sale of fragrances through four business units: Fine Fragrances, comprising fragrances; Consumer Products, comprising personal care, hair and skin care, household care, and oral care; Fragrance Ingredients; and Cosmetics Activities, comprising cosmetics. The Flavors business division comprises the manufacture and sale of flavors into four business units: Beverages, comprising flavors for soft drinks, fruit juices and instant beverages; Dairy, comprising ice cream, yoghurt, desserts and yellow fats; Savory, covering soups and sauces; and Confectionery. The Company also engages in research and development activities into perfumery raw materials, both synthetic and natural. It operates through Induchem Holding AG and Activ International, among others.

  • Revenue in CHF (TTM)6.92bn
  • Net income in CHF893.00m
  • Incorporated1929
  • Employees16.26k
  • Location
    Givaudan SAChemin de la Parfumerie 5VERNIER 1214SwitzerlandCHE
  • Phone+41 227809111
  • Fax+41 227809150
  • Websitehttps://www.givaudan.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Imcd NV4.39bn289.01m7.90bn4.74k27.314.6319.661.805.135.1378.0530.301.145.726.19938,057.907.497.019.869.6022.4821.406.585.801.157.980.493244.25-3.4513.30-6.6523.9124.0922.87
PhosAgro PAO4.39bn859.05m7.99bn25.00k9.305.296.701.82664.74664.743,400.031,170.050.89745.727.83--17.5624.7126.1632.8942.9445.8519.5624.160.60996.080.62398.72-22.6913.54-53.3831.2910.868.67
Evonik Industries AG14.89bn-352.02m9.31bn33.09k--1.038.780.6251-0.7797-0.779732.5219.610.70934.327.87450,716.90-1.612.01-2.012.4218.8525.47-2.262.900.877210.340.3353130.72-17.422.85-186.27---3.510.3454
Brenntag SE16.11bn633.25m9.61bn17.70k15.882.169.410.59634.244.24107.5231.081.508.006.30919,905.105.966.408.669.0224.3023.033.984.021.1414.890.376137.40-13.456.03-19.389.1812.47-21.40
Syensqo SA-98.88bn-98.88bn9.78bn13.05k--1.28----------73.09------------------------1.33--0.2292---13.02---79.68------
Akzo Nobel NV10.53bn528.03m10.91bn35.50k20.692.4111.791.043.133.1062.1626.820.73523.493.91302,585.203.984.156.506.0640.7440.515.426.070.779511.340.516163.75-1.642.8823.482.2512.321.41
Novozymes A/S2.37bn400.76m23.35bn6.40k39.068.4338.769.8410.8810.8864.4050.400.6352.204.852,798,030.0010.7813.4614.6917.8454.3255.5616.9820.120.803538.910.350238.891.974.46-17.74-1.288.114.40
Givaudan SA6.92bn893.00m39.14bn16.26k43.949.8031.345.6696.4896.48747.06432.740.6113.024.67425,198.307.897.419.589.0141.1641.0712.9112.081.1412.580.550975.20-2.844.584.326.149.272.53
BASF SE65.72bn30.65m42.75bn111.86k1,394.361.168.410.65050.03470.034774.4741.640.79183.304.83593,485.200.22041.680.28742.1924.6824.960.27832.001.238.620.3528247.02-21.102.73135.89-43.316.741.22
Sika AG11.24bn1.06bn45.56bn33.55k43.017.6929.434.056.606.6070.9736.900.85244.256.03335,010.608.069.2510.1711.5053.6152.499.4510.340.866712.290.49639.687.129.67-8.659.233.249.99
L'Air Liquide Sct nnym pr l'td t l'xpltt27.30bn3.04bn94.19bn67.78k30.943.9116.813.455.875.8752.6846.490.56435.599.16407,323.906.516.018.107.3859.6259.6911.5311.070.635619.090.324656.32-7.775.6111.577.818.577.88
Data as of May 24 2024. Currency figures normalised to Givaudan SA's reporting currency: Swiss Franc CHF

Institutional shareholders

29.49%Per cent of shares held by top holders
HolderShares% Held
Bill & Melinda Gates Foundation Trust (Investment Management)as of 31 Dec 20231.28m13.86%
The Vanguard Group, Inc.as of 09 May 2024296.81k3.21%
UBS Asset Management Switzerland AGas of 30 Jun 2023287.86k3.12%
Norges Bank Investment Managementas of 31 Dec 2023167.59k1.82%
BlackRock Fund Advisorsas of 09 May 2024158.87k1.72%
Credit Suisse Asset Management (Schweiz) AGas of 29 Feb 2024123.09k1.33%
Z�rcher Kantonalbank (Investment Management)as of 28 Mar 2024113.10k1.23%
Pictet Asset Management SAas of 30 Apr 2024106.91k1.16%
BlackRock Advisors (UK) Ltd.as of 09 May 202499.31k1.08%
Geode Capital Management LLCas of 16 May 202489.27k0.97%
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.